Josep M. Campistol

36.4k total citations · 7 hit papers
567 papers, 19.6k citations indexed

About

Josep M. Campistol is a scholar working on Transplantation, Surgery and Molecular Biology. According to data from OpenAlex, Josep M. Campistol has authored 567 papers receiving a total of 19.6k indexed citations (citations by other indexed papers that have themselves been cited), including 204 papers in Transplantation, 157 papers in Surgery and 115 papers in Molecular Biology. Recurrent topics in Josep M. Campistol's work include Renal Transplantation Outcomes and Treatments (203 papers), Organ Transplantation Techniques and Outcomes (74 papers) and Metabolism and Genetic Disorders (56 papers). Josep M. Campistol is often cited by papers focused on Renal Transplantation Outcomes and Treatments (203 papers), Organ Transplantation Techniques and Outcomes (74 papers) and Metabolism and Genetic Disorders (56 papers). Josep M. Campistol collaborates with scholars based in Spain, United States and France. Josep M. Campistol's co-authors include Álex Gutiérrez-Dalmau, Fritz Diekmann, José‐Vicente Torregrosa, J.M. Morales, Federico Oppenheimer, Henri Kreis, Francisco Maduell, John F. Neylan, Juan Carlos Izpisúa Belmonte and Francesco Paolo Schena and has published in prestigious journals such as New England Journal of Medicine, Cell and Journal of Biological Chemistry.

In The Last Decade

Josep M. Campistol

555 papers receiving 19.1k citations

Hit Papers

SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSP... 1999 2026 2008 2017 1999 2017 2013 2007 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josep M. Campistol Spain 64 6.6k 5.5k 4.4k 3.5k 2.8k 567 19.6k
Dirk Kuypers Belgium 69 8.8k 1.3× 4.1k 0.8× 1.8k 0.4× 3.5k 1.0× 1.9k 0.7× 352 16.0k
Gerhard Opelz Germany 74 9.4k 1.4× 6.7k 1.2× 2.4k 0.6× 1.8k 0.5× 3.1k 1.1× 645 22.6k
Christophe Legendre France 76 9.1k 1.4× 5.1k 0.9× 1.5k 0.3× 4.3k 1.2× 3.6k 1.3× 426 18.5k
Philip F. Halloran Canada 87 18.3k 2.8× 12.3k 2.2× 3.3k 0.8× 4.7k 1.3× 3.6k 1.3× 454 28.0k
Mohamed H. Sayegh United States 91 5.2k 0.8× 7.3k 1.3× 5.3k 1.2× 1.3k 0.4× 2.2k 0.8× 383 30.4k
Hermann Haller Germany 80 2.1k 0.3× 4.1k 0.7× 7.0k 1.6× 4.4k 1.3× 2.0k 0.7× 454 23.0k
Norberto Perico Italy 65 3.2k 0.5× 3.7k 0.7× 2.6k 0.6× 3.6k 1.0× 853 0.3× 292 14.2k
Ulrich Frei Germany 50 2.9k 0.4× 2.9k 0.5× 1.9k 0.4× 2.5k 0.7× 1.7k 0.6× 242 11.4k
Flavio Vincenti United States 66 9.6k 1.5× 5.3k 1.0× 1.1k 0.2× 2.5k 0.7× 3.6k 1.3× 270 16.4k
Joseph P. Grande United States 71 2.2k 0.3× 2.8k 0.5× 4.2k 1.0× 3.8k 1.1× 939 0.3× 284 15.0k

Countries citing papers authored by Josep M. Campistol

Since Specialization
Citations

This map shows the geographic impact of Josep M. Campistol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep M. Campistol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep M. Campistol more than expected).

Fields of papers citing papers by Josep M. Campistol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep M. Campistol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep M. Campistol. The network helps show where Josep M. Campistol may publish in the future.

Co-authorship network of co-authors of Josep M. Campistol

This figure shows the co-authorship network connecting the top 25 collaborators of Josep M. Campistol. A scholar is included among the top collaborators of Josep M. Campistol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep M. Campistol. Josep M. Campistol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herrera, Sabina, Ignasi Roca, Ana del Rı́o, et al.. (2024). Performance of an Autonomous Sanitary Sterilisation Ultraviolet Machine (ASSUM) on terminal disinfection of surgical theaters and rooms of an intensive-intermediate care unit. Infection Prevention in Practice. 6(4). 100396–100396. 1 indexed citations
2.
Rovira, Jordi, María José Ramírez-Bajo, Elisenda Bañón-Maneus, et al.. (2023). Chimeric HLA antibody receptor T cells for targeted therapy of antibody‐mediated rejection in transplantation. HLA. 102(4). 449–463. 3 indexed citations
3.
Youssef, L., F. Crovetto, Rui V. Simões, et al.. (2022). The Interplay between Pathophysiological Pathways in Early-Onset Severe Preeclampsia Unveiled by Metabolomics. Life. 12(1). 86–86. 17 indexed citations
4.
Montagud‐Marrahí, Enrique, Ignacio Revuelta, David Cucchiari, et al.. (2020). Successful use of nonantigen‐specific immunoadsorption with antihuman Ig‐columns in kidney graft antibody‐mediated rejection. Journal of Clinical Apheresis. 35(3). 188–199. 3 indexed citations
5.
Lozano, Juan José, Elisenda Bañón-Maneus, Jordi Rovira, et al.. (2019). Effect of immunosuppression in miRNAs from extracellular vesicles of colorectal cancer and their influence on the pre-metastatic niche. Scientific Reports. 9(1). 11177–11177. 15 indexed citations
6.
Maduell, Francisco, J. Sánchez, M. Net, et al.. (2015). Mathematical Modeling of Different Molecule Removal on On-Line Haemodiafiltration: Influence of Dialysis Duration and Infusion Flow. Blood Purification. 39(4). 288–296. 6 indexed citations
7.
Diekmann, Fritz & Josep M. Campistol. (2015). Practical considerations for the use of mTOR inhibitors. PubMed. 4(S1). 13–17. 7 indexed citations
8.
Miró, José M., Frederic Cofán, Joan Carles Trullàs, et al.. (2012). Renal Dysfunction in the Setting of HIV/AIDS. Current HIV/AIDS Reports. 9(3). 187–199. 21 indexed citations
9.
Fontseré, Néstor, Miquel Blasco, Marta Arias‐Guillén, et al.. (2010). Is ionic dialysance useful for early detection of vascular access dysfunction? Six illustrative cases. Hemodialysis International. 15(1). 108–111. 6 indexed citations
10.
Brouard, Sophie, Juan José Lozano, Annaïck Pallier, et al.. (2010). Comparative Transcriptional and Phenotypic Peripheral Blood Analysis of Kidney Recipients Under Cyclosporin A or Sirolimus Monotherapy. American Journal of Transplantation. 10(12). 2604–2614. 40 indexed citations
11.
Lario, Sergio, M Bescós, Begoña Campos, et al.. (2007). Thrombospondin-1 mRNA expression in experimental kidney transplantation with heart-beating and non-heart-beating donors. Journal of Nephrology. 20(5). 588–595. 15 indexed citations
12.
Trullàs, Joan Carles, Frederic Cofán, Stefania Cocchi, et al.. (2007). Short Communication: Effect of Thymoglobulin Induction on HIV-Infected Renal Transplant Recipients: Differences between HIV-Positive and HIV-Negative Patients. AIDS Research and Human Retroviruses. 23(10). 1161–1165. 22 indexed citations
13.
Campistol, Josep M., Josette Eris, Rainer Oberbauer, et al.. (2006). Sirolimus Therapy after Early Cyclosporine Withdrawal Reduces the Risk for Cancer in Adult Renal Transplantation. Journal of the American Society of Nephrology. 17(2). 581–589. 373 indexed citations
14.
Baltar, José, et al.. (2004). Quality of life of patients with chronic renal allograft rejection and anemia. Journal of Nephrology. 17(4). 531–536. 13 indexed citations
15.
Ruiz, Juan Carlos, Josep M. Campistol, A. Mota, et al.. (2003). Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions. Transplantation Proceedings. 35(5). 1669–1670. 16 indexed citations
16.
Cofán, Frederic, et al.. (2002). [Atypical cytomegalovirus in renal transplantation: a new form of presentation].. PubMed. 22(4). 381–5. 5 indexed citations
17.
Kreis, Henri, Jean‐Marc Cisterne, W. Land, et al.. (2000). SIROLIMUS IN ASSOCIATION WITH MYCOPHENOLATE MOFETIL INDUCTION FOR THE PREVENTION OF ACUTE GRAFT REJECTION IN RENAL ALLOGRAFT RECIPIENTS12. Transplantation. 69(7). 1252–1260. 456 indexed citations
18.
Booth, David R., Shouyong Tan, S E Booth, et al.. (1996). Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene.. Journal of Clinical Investigation. 97(12). 2714–2721. 75 indexed citations
19.
Campistol, Josep M., et al.. (1993). Synthesis of ,β2-Microglobulin in Lymphocyte Culture: Role of Hemodialysis, Dialysis Membranes, Dialysis-Amyloidosis, and Lymphokines. American Journal of Kidney Diseases. 22(5). 691–699. 9 indexed citations
20.
Campistol, Josep M., et al.. (1982). Ensayo terapéutico con alopurinol en la distrofia muscular progresiva tipo Duchenne. Anales de Pediatría. 16(1). 42–46. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026